 |
Articles: Dosing |
Effectiveness of fluticasone furoate 110 micro g once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen
Current Medical Research and Opinion, 06/26/09
Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer
Annals of Oncology, 06/26/09 A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies
Clinical Cancer Research, 06/25/09 A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression
Journal of Acquired Immune Deficiency Syndromes, 06/25/09 Do PPIs and H2-blockers increase the risk of hip fractures
American Pharmacists Association, 06/25/09
Free full text
Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis
BJU International, 06/24/09 Treatment of Disseminated Granuloma Annulare with Low-dose Fumaric Acid
Acta Dermato-Venereologica, 06/24/09 Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily
Cancer, 06/23/09 Pain Responder Analysis: Use of Area Under the Curve to Enhance Interpretation of Clinical Trial Results
Pain Practice, 06/23/09 Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: An open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers
Clinical Therapeutics, 06/23/09 Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension
Expert Opinion in Pharmacotherapy, 06/22/09 Human genome sciences announces completion of enrollment in phase 2b monthly-dosing trial of albuferon
Human Genome Sciences, 06/22/09
Free full text
Medical treatment of vestibular disorders
Expert Opinion in Pharmacotherapy, 06/19/09 Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen
Contraception, 06/19/09 Therapeutic potential of n-3 polyunsaturated fatty acids in disease
American Journal of Health-System Pharmacy, 06/18/09 The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril
Expert Opinion in Pharmacotherapy, 06/17/09 Thrombotic eosinophilic vasculitis
Clinical and Experimental Dermatology, 06/16/09 Comparison of Immediate-Release and Controlled-Release Paroxetine Ingestions Reported to Texas Poison Control Centers Between 2002 and 2008
Journal of Pharmacy Technology, 06/16/09 Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
Pharmacogenetics and genomics, 06/15/09 A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients
World Journal of Gastroenterology, 06/15/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
